Articles Tagged with Xarelto injury lawyer

Published on:

Drug companies are big multinational corporations for the most part, and as such report their profits and losses to Wall Street each quarter. That means these firms are very concerned about making money for their shareholders and their executives.  There is no question many medicines they make save a lot of lives. However, when the desire to rake in a profit overshadows the desire to keep people safe and healthy, problems arise.

white pillsOne of the drugs that makes a lot of money for Bayer AG is known as Xarelto.  Xarelto is part of a relatively new class of drugs called new oral anticoagulants (NOACs).  Xarelto is one NOAC manufactured by the German pharmaceutical giant and marketed by its partner in the U.S., Johnson & Johnson, but there other competitors. Those include Savaysa, Elliquis, and Pradaxa.  These drugs are not only competing with each other, but they are also competing with Warfarin (Coumadin).

A recent news article from Yahoo shows that Xarelto was helping drive company sales this past fiscal quarter.

Continue reading

Published on:

According to a recent news article from the Cook County Record, a woman has just filed a lawsuit against Bayer and Johnson & Johnson/Janssen Pharmaceuticals, who are the makers and U.S. marketing partners of the New Oral Anticoagulant (NOAC) Xarelto.

whitepillsThis lawsuit alleges that, after taking Xarelto, she suffered serious physical injury.  She is alleging that the drug Xarelto was defectively designed, causing her to suffer these severe medical effects and that the companies failed to warn her of these known defects. Continue reading

Published on:

According to a recent report from WebMD News, a recent study, which asserted both Xarelto and Pradaxa were superior to Warfarin, found that Xarelto poses a higher risk of serious internal bleeding disorders than its competitor, Pradaxa. The drugs at issue are part of a new class of anticoagulants known as New Oral Anticoagulants (NOACs).  Xarelto, Pradaxa, Eliquis, and Savaysa are the four NOACs approved by the United States Food and Drug Administration (FDA).

untitled-1238929-mThe risk of increased internal bleeding disorders for patients taking Xarelto over patients taking Pradaxa was seen in patients who suffer from a serious medical condition known as atrial fibrillation (Afib).  Afib, is characterized by an irregular heartbeat not caused by a heart valve defect.  If this sounds familiar to you even though you do not suffer from Afib, it might be because Saturday Night Live alumni actor Kevin Nealon appears in a commercial where he discusses his own struggles with Afib and how taking Xarelto has helped him to lead a normal life. Continue reading

Published on:

According to a recent news article from the Louisiana Record, the surviving daughter of a man from Ohio claims that her father died as a result of complications due to taking Xarelto.  The complaint was filed on April 8, 2016 in a United States District Court.  Plaintiff filed the suit against Janssen, which is the marketing arm of Johnson & Johnson and the United States marketing partner for Xarelto.  The plaintiff also named Bayer, which is the German pharmaceutical giant that manufactures Xarelto.packofpills

The claims included in the complaint are for fraud, breach of an express or implied warranty, defective design, failure to warn of a known danger, wrongful death, and negligent misrepresentation.  Continue reading

Published on:

Xarelto, Eliquis, Pradaxa, and the newly-marketed Savaysa are all members of a class of drugs known as New Oral Anticoagulants (NOACs). They are all advertised as a safer and easier to use alternative to Warfarin (Coumadin), which has been the long-standing drug prescribed to patients who suffer from an irregular heartbeat condition known as atrial fibrillation (Afib).

pills-1023897-mAfib patients require either a blood thinner like Warfarin or an oral anticoagulant like Xarelto to decrease the risk they will develop a serious clotting disorder.   If patient develops clots deep within the veins of his or her legs, which is known as deep vein thrombosis (DVT), the clots can break loose and travel to the lungs, where they can puncture the tissue, causing a potentially deadly condition known as pulmonary embolism (PE). The clots can also block blood flow to the brain, which results in a stroke. Continue reading